Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04733638 · ClinicalTrials.gov registry record
ADVANCE- Automated Detection and Volumetric Assessment of ICH
A clinical trial, sponsored by Viz.ai.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT04733638: Completed study, sponsored by Viz.ai.
NCT04733638 is a clinical trial that has completed, run by Viz.ai. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04733638 has completed, sponsored by Viz.ai.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
To evaluate the performance of the Viz ICH VOLUME algorithm.
Primary Outcome
Sensitivity and specificity of Viz ICH VOLUME in detecting ICH compared to standard of care evaluation.
Interventions
- DEVICE Viz ICH VOLUME
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2021-01-26 |
| Est. Completion | 2023-04-28 |
What the finished NCT04733638 record still lists
NCT04733638 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Viz ICH VOLUME is the first listed.
NCT04733638 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04733638 about?
NCT04733638 is a clinical study titled "ADVANCE- Automated Detection and Volumetric Assessment of ICH". To evaluate the performance of the Viz ICH VOLUME algorithm.
What is the current status of trial NCT04733638?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2021-01-26. Estimated completion is 2023-04-28.
What interventions are being tested in trial NCT04733638?
The interventions under investigation include: Viz ICH VOLUME (DEVICE).
Who is sponsoring clinical trial NCT04733638?
This trial is sponsored by Viz.ai, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI